CARDIOVASCULAR
hamburger

Suture-Mediated Closure For Both Arterial And Venous Access

Perclose ProGlide™ SMC System delivers a secure, non-masking percutaneous suture to the access site that promotes primary healing3 and has no re-access restrictions.

This system has the broadest arterial and venous indication*; it can be utilized for 5-21F2 (Max. 26F OD1) arterial sheaths and 5-24F2 (Max. 29F OD1) venous sheaths. Abbott’s Perclose ProGlide™ SMC System also offers the following benefits:

  • Reduced time to hemostasis, ambulation and discharge compared to manual compression4,5
  • Ability to challenge and confirm closure on the table5
  • Minimized inflammatory response5
  • Significantly lower blood transfusions, infections, mortality, and shorter length of stay compared to surgical cutdown for large bore-arterial access6
  • Low major access site-related complications for large-bore venous access7

For EP labs, click here to discover how Perclose ProGlide™ SMC System can improve EP lab workflow and enhance patient experience.

Perclose ProGlide
Perclose ProGlide
Perclose ProGlide

Broadest Indication*

The Perclose ProGlide™ vascular closure system has the broadest indication for both femoral arterial and venous access

For common femoral access sites

Artery and Vein OD chart

Suture-based

The use of Perclose ProGlide™ for repair of large bore arterial access is associated with significantly lower blood transfusions, infections, mortality, and length of stay compared to cutdown.6

The use of Perclose ProGlide™ for large-bore venous access is also associated with low major access site-related complications.7

Primary Intention

Parallels the Surgical Gold Standard
  • Associated with significantly lower blood transfusions, infections, mortality, and shorter length of stay compared to surgical cutdown6
  • Secure repair with pre-tied polypropylene monofilament suture
  • Minimal intravascular footprint

 

Promotes Vessel Healing
  • Minimizes inflammatory response5
  • No re-access restrictions after using Abbott vascular closure devices

 

Gives In-Lab Confidence
  • Low access site-related complication,6,7 reduces time to hemostasis, ambulation, and discharge as compared to manual compression4,5
  • Suture repair can be challenged and confirmed on the table5
  • Ability to maintain wire access

Clean Incision

Clean Incision

Early Suture

Early Suture

"Hairline" Scar

References

*As compared to Angio-Seal, MANTA, Celt ACD, ExoSeal, Mynx, Vascade. Data on file at Abbott.

  1. Max. OD 26F/0.340 inches/8.62 mm; Max. OD 29F/0.378 inches/9.59 mm. Tests performed by and data on file at Abbott.
  2. For sheath sizes greater than 8F, at least two devices and pre-close technique are required. U.S. Perclose ProGlide™ SMC System Instructions for Use.
  3. Primary intention healing occurs where vessel wall edges are brought together, adjacent to each other. This can be achieved with sutures and other methods. Advances in Skin & Wound Care: Healing by Intention. Salcido, Richard. 2017
  4. Time to hemostasis, ambulation and discharge applies to the arterial access. U.S. Perclose ProGlide™ SMC System Instructions for Use.
  5. U.S. Perclose ProGlide™ SMC System Instructions for Use.
  6. Perclose ProGlide™ Versus Surgical Closure Outcomes – Real World Evidence. Schneider, Darren B; Krajcer, Zvonimir; et al. LINC 2018.
  7. The Use of the Perclose ProGlide™ Suture Mediated Closure (SMC) Device for Venous Access-Site Closure up to 24F Sheaths. Kar, Saibal; Hermiller, James; et al. CRT 2018.
Important Safety Information

MAT-2002632 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.